Sfoglia per Autore
Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
1997 Pietrini, P; Dani, A; Furey, M. L.; Alexander, G. E.; Freo, Ulderico; Grady, C. L.; Mentis, M. J.; Mangot, D; Simon, E. W.; Horwitz, B; Haxby, J. V.; Schapiro, M. B.
The effects of propofol on cerebral high energy metabolites, lactate, and glucose in normoxic and severely hypoxic rats
1997 Ori, Carlo; Cavallini, L; Freo, Ulderico; Ruggero, S; Ermani, Mario; Pizzolato, G; Dam, Mauro
Cerebral Metabolic Effects of Serotonin Drugs and Neurotoxins. A review article.
1996 Freo, Ulderico
The effects of fluoxetine and maprotiline on functional recovery in post-stroke hemiplegic patients undergoing rehabilitation therapy. Stroke, 27, 1221-1214 (1996)
1996 Dam, Mauro; Tonin, P; DE BONI, A; Pizzolato, Gilberto; Casson, S; Ermani, Mario; Freo, Ulderico; Piron, L; Battistin, Leontino
Visual variant of Alzheimer's disease: a unique neuropsychological profile.
1996 FUREY KURKJIAN, M; Pietrini, P; GRAFF REDFORD, N; Alexander, G; Freo, Ulderico; Szczepanik, J; S., Rapoport; Schapiro, M.
Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
1996 Pietrini, P; FUREY M., L; GRAFF RADFORD, N; Freo, Ulderico; ALEXANDER G., E; GRADY C., L; Dani, A; MENTIS M., J; Schapiro, M. B.
Brain cognition and metabolism in Down syndrome adults in association with development of dementia.
1996 Dani, A; Pietrini, P; Furey, M. L.; Mcintosh, A. R.; Grady, C. L.; Horwitz, B; Freo, Ulderico; Alexander, G. E.; Schapiro, M. B.
The effects of fluoxetine on local cerebral glucose utllisation of awake rats
1995 Freo, Ulderico; Dam, Mauro; Pizzolato, Gilberto; Merico, Antonio; Ori, Carlo; Sale, E; Battistin, Leontino
Behavioral and cerebral metabolic effects of the 5-HT1A agonists buspirone and 8-OH-DPAT.
1995 Freo, Ulderico; P., Pietrini; G., Pizzolato; FUREY KURKJIAN, M. L.; Merico, A; Ruggero, A; Dam, M; Battistin, L.
Cerebral metabolic responses to clomipramine persist only in raphe-hippocampal system of rats pretreated with the specific neurotoxin parachloroamphetamine.
1995 Freo, Ulderico; Pietrini, P; Pizzolato, Gilberto; Merico, A; Ruggero, S; Dam, Mauro; Battistin, Leontino
Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory.
1994 FUREY M., L; Pietrini, P; HAXBY J., V; ALEXANDER G., E; LEE H., C; Vanmeter, J; GRADY C., L; Shetty, U; RAPOPORT S., I; SCHAPIRO M., B; Freo, Ulderico
Cerebral metabolic responses to meta-chlorophenylpiperazine are reduced during its chronic administration to young and aged rats.
1993 Freo, Ulderico; Larson, D. L.; Soncrant, T. T.
Time- and dose-dependent effects of the serotonergic agent quipazine on regional cerebral metabolism in rats.
1993 Freo, Ulderico; RICCHIERI G., L; HOLLOWAY H., W; Soncrant, T. T.
The tricyclic antidepressant clomipramine dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats.
1993 Freo, Ulderico; Pietrini, P; Dam, Mauro; Pizzolato, Gilberto; Battistin, Leontino
The monosialoganglioside GM1 dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats.
1993 Freo, Ulderico; Dam, Mauro; Pizzolato, Gilberto; Pietrini, P; Soncrant, T. T.; Battistin, Leontino
Chronic treatment with meta-chlorophenylpiperazine (MCPP) reduces behavioral and cerebral metabolic responses to MCPP and to quipazine but not to 8-hydroxy-2(di-N-propylamino)tetralin.
1992 Freo, Ulderico; SONCRANT T., T; HOLLOWAY H., W; GREIG N., H; Rapoport, S. I.
Adrenalectomy or metyrapone-pretreatment abolishes cerebral metabolic responses to the serotonin agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the hippocampus.
1992 Freo, Ulderico; Holloway, H. W.; Kalogeras, K; Rapoport, S. I.; Soncrant, T. T.
Age-related alterations in behavioral and metabolic responses to the serotoninergic agonist meta-chlorophenylpiperazine.
1991 Freo, Ulderico; SONCRANT T., T; Rapoport, S. I.
Parachloroamphetamine selectively alters the metabolic responses to the serotonin agonist meta-chlorophenylpiperazine.
1991 Freo, Ulderico; Larson, D. M.; Tolliver, T; Rapoport, S. I.; Soncrant, T. T.
Dose- and time-dependent effects of 1(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on local cerebral glucose metabolism in awake rats.
1991 Freo, Ulderico; Holloway, H. W.; Soncrant, T. T.; Rapoport, S. I.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile